Year |
Citation |
Score |
2020 |
Ashraf A, Jeandriens J, Parkes HG, So PW. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosis. Redox Biology. 32: 101494. PMID 32199332 DOI: 10.1016/J.Redox.2020.101494 |
0.302 |
|
2020 |
Beloueche-Babari M, Casals Galobart T, Delgado-Goni T, Wantuch S, Parkes HG, Tandy D, Harker JA, Leach MO. Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration. British Journal of Cancer. PMID 31937921 DOI: 10.1038/S41416-019-0717-X |
0.301 |
|
2019 |
Gardner A, Parkes HG, So P, Carpenter GH. Determining bacterial and host contributions to the human salivary metabolome Journal of Oral Microbiology. 11: 1617014. DOI: 10.1080/20002297.2019.1617014 |
0.306 |
|
2018 |
Gardner A, Parkes HG, Carpenter GH, So PW. Developing and Standardising a Protocol for Quantitative Proton Nuclear Magnetic Resonance (H-NMR) Spectroscopy of Saliva. Journal of Proteome Research. PMID 29498859 DOI: 10.1021/Acs.Jproteome.7B00847 |
0.358 |
|
2017 |
Beloueche-Babari M, Wantuch S, Casals Galobart T, Koniordou M, Parkes HG, Arunan V, Chung YL, Eykyn TR, Smith PD, Leach MO. MCT1 inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and non-invasive magnetic resonance spectroscopy. Cancer Research. PMID 28923861 DOI: 10.1158/0008-5472.Can-16-2686 |
0.396 |
|
2016 |
Delgado-Goni T, Falck Miniotis M, Wantuch S, Parkes HG, Marais R, Workman P, Leach MO, Beloueche-Babari M. The BRAF inhibitor vemurafenib activates mitochondrial metabolism and inhibits hyperpolarized pyruvate-lactate exchange in BRAF mutant human melanoma cells. Molecular Cancer Therapeutics. PMID 27765851 DOI: 10.1158/1535-7163.Mct-16-0068 |
0.414 |
|
2013 |
Hill DK, Orton MR, Mariotti E, Boult JK, Panek R, Jafar M, Parkes HG, Jamin Y, Miniotis MF, Al-Saffar NM, Beloueche-Babari M, Robinson SP, Leach MO, Chung YL, Eykyn TR. Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data. Plos One. 8: e71996. PMID 24023724 DOI: 10.1371/Journal.Pone.0071996 |
0.35 |
|
2013 |
Walker-Samuel S, Ramasawmy R, Torrealdea F, Rega M, Rajkumar V, Johnson SP, Richardson S, Gonçalves M, Parkes HG, Arstad E, Thomas DL, Pedley RB, Lythgoe MF, Golay X. In vivo imaging of glucose uptake and metabolism in tumors. Nature Medicine. 19: 1067-72. PMID 23832090 DOI: 10.1038/Nm.3252 |
0.462 |
|
2007 |
So PW, Parkes HG, Bell JD. Application of magnetic resonance methods to studies of gene therapy Progress in Nuclear Magnetic Resonance Spectroscopy. 51: 49-62. DOI: 10.1016/J.Pnmrs.2007.02.001 |
0.304 |
|
2003 |
Southworth R, Parry CR, Parkes HG, Medina RA, Garlick PB. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat. Nmr in Biomedicine. 16: 494-502. PMID 14696007 DOI: 10.1002/Nbm.856 |
0.359 |
|
1998 |
Garlick PB, Marsden PK, Cave AC, Parkes HG, Slates R, Shao Y, Silverman RW, Cherry SR. PET and NMR dual acquisition (PANDA): applications to isolated, perfused rat hearts. Nmr in Biomedicine. 10: 138-42. PMID 9408923 DOI: 10.1002/(Sici)1099-1492(199705)10:3<138::Aid-Nbm474>3.0.Co;2-H |
0.465 |
|
1997 |
Marsden PK, Shao Y, Cherry SR, Cave A, Parkes HG, Silverman RW, Slates R, Meadors K, Bowery A, Garlick PB. 76. Simultaneous acquisition of PET images and NMR spectra in a high field magnet Nuclear Medicine Communications. 18: 311. DOI: 10.1097/00006231-199704000-00078 |
0.377 |
|
Show low-probability matches. |